<?xml version="1.0" encoding="UTF-8"?>
<p>Despite great improvements in the time-to-result and the excellent sensitivity and specificity provided by nucleic acid-based approaches to test for infectious diseases (PCR, sequencing, and DNA microarrays) [
 <xref rid="B6-antibodies-08-00023" ref-type="bibr">6</xref>,
 <xref rid="B7-antibodies-08-00023" ref-type="bibr">7</xref>], serological methods have a number of advantages including their low cost, multiplexing capacity and ease of coupling to simple devices such as lateral flow tests for use with minimal or no laboratory infrastructures. 
</p>
